RASOOL, A. M. A.; RASHID, A. M. S.; HASSAN , E. H. A.; SUBHI, A. REPURPOSING ORLISTAT AS A FATTY ACID SYNTHASE INHIBITOR IN BREAST CANCER: IN VITRO EFFICACY, MECHANISMS, AND SYNERGY WITH DOXORUBICIN. Journal of Medical Genetics and Clinical Biology, [S. l.], v. 3, n. 1, p. 73–89, 2025. DOI: 10.61796/jmgcb.v3i1.1606. Disponível em: https://journal.antispublisher.id/index.php/JMGCB/article/view/1606. Acesso em: 27 feb. 2026.